Last updated at 04 Nov 2025 02:57 AM
Director
DIN: 09683965
Mansi Aggarwal is currently associated with 3 companies as Director. They serve as a Director at WUZE PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09683965.Mansi Aggarwal has previously been associated with 1 company in roles such as Additional Director.Mansi Aggarwal is currently involved in 1 different role. Their most recent position is with COMECE INTERNATIONAL PRIVATE LIMITED as a Director. The first company Mansi Aggarwal was appointed to as a director was WUZE PHARMACEUTICALS PRIVATE LIMITED. Mansi Aggarwal is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Mansi Aggarwal is currently associated with 3 companies as Director. They serve as a Director at WUZE PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09683965.Mansi Aggarwal has previously been associated with 1 company in roles such as Additional Director.Mansi Aggarwal is currently involved in 1 different role. Their most recent position is with COMECE INTERNATIONAL PRIVATE LIMITED as a Director. The first company Mansi Aggarwal was appointed to as a director was WUZE PHARMACEUTICALS PRIVATE LIMITED. Mansi Aggarwal is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Female
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (1)
8 Months 4 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| WUZE PHARMACEUTICALS PRIVATE LIMITED | Director | 30-Sep-2022 |
| WUZE INTERNATIONAL PRIVATE LIMITED | Director | 12-Mar-2025 |
| COMECE INTERNATIONAL PRIVATE LIMITED | Director | 04-Jun-2025 |